Back

Methylome of circulating cell free DNA as a novel biomarker tool: from acute coronary syndrome to broader risk stratification of cardiovascular disease

2 September 2024 (12:00 - 12:50)
Organised by: Logo
Congress Presentation Part of: Acute and chronic coronary syndromes Noninvasive Diagnostic Methods ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Adelheid Kratzer

German Heart Institute Berlin, Berlin (Germany)

6 More presentations in this session

Presentation thumbnail
How to predict myocardial injury in patients with large ischaemic burden identified during stress echocardiography?
Doctor K. Vakalis (Harefield, Uxbridge, GB)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of Shexiang Baoxin pill in patients with ischemia with non-obstructive coronary arteries (LESS): a phase 4, multicenter, randomized, double-blind, placebo-controlled clinical trial
Professor N. Li (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Longitudinal and cross-sectional associations of NT-proBNP with kidney function and chronic kidney disease: results from KORA cohort studies
Mr J. Lin (Neuherberg, DE)
Abstract Slides Video
Presentation thumbnail
Coronary sinus reducer device for the treatment of refractory angina: a single center experience
Doctor M. Sobral Domingues (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Symptomatic patients without coronary artery disease do not have excess cardiovascular risk compared to the general population
Doctor K. Olesen (Aarhus, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Acute and chronic coronary syndromes

The Event

Event poster

ESC Congress 2024

2 September 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Identification of a DNA methylation signature for worsening of heart failure
thumbnail
Congress Session
Novel biomarkers for cardiovascular risk assessment
thumbnail
Congress Presentation
Which biomarkers are useful to risk stratify in primary prevention?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources